Type 2 Diabetes Serum
Powered by BiozAbout:Type 2 Diabetes Serum — human serum from consented donors with clinically confirmed type 2 diabetes, processed and frozen within 24 hours of collection. Suited to metabolic inflammation, adipokine and insulin-axis profiling, lipid and complication-marker research. Donors can be stratified by HbA1c band, treatment class, BMI, and complication status.
About Type 2 Diabetes Serum
Human Type 2 Diabetes Serum for Metabolic and Endocrine Research
Our Type 2 Diabetes Serum is sourced from IRB-consented donors clinically diagnosed with type 2 diabetes (T2D). Each sample is processed and frozen within 24 hours of collection to ensure consistency and high quality for metabolic, endocrine and biomarker research. Type 2 diabetes is a metabolic disease characterised by insulin resistance in liver, muscle and adipose tissue together with progressive beta-cell secretory failure — a fundamentally different mechanism from the autoimmune beta-cell destruction of type 1 diabetes.
Why Serum for Type 2 Diabetes Research
- Serum is the conventional matrix for the endocrine axis of T2D: insulin, C-peptide and proinsulin measurements support work on residual beta-cell secretory capacity and on the degree of insulin resistance.
- Adipose tissue is an endocrine organ in T2D. Adipokines such as leptin and adiponectin, and the adipose-derived inflammatory mediators TNF-alpha and IL-6, are measurable in serum and underpin the concept of metabolic inflammation — a chronic low-grade inflammatory state driven by nutrient excess rather than by autoimmunity.
- High-sensitivity CRP and related acute-phase reactants link that low-grade inflammation to the elevated cardiovascular risk that dominates T2D outcomes.
- Serum supports the full clinical chemistry panel relevant to diabetic complications in a single matrix: lipid fractions, creatinine for eGFR estimation, and liver enzymes relevant to concurrent metabolic liver disease.
- Because serum lacks anticoagulant, it is well suited to immunoassay and mass spectrometry platforms where citrate or EDTA carryover interferes, and it is the matrix in which most published diabetes biomarker reference data were generated.
- Advanced glycation end-products and glycated protein species accumulate systemically in sustained hyperglycaemia and can be interrogated in serum alongside conventional glycaemic indices.
Donor Stratification Available
- Glycaemic control band by most recent HbA1c, where reported
- Treatment class: lifestyle/diet-managed, metformin monotherapy, GLP-1 receptor agonist, SGLT2 inhibitor, sulfonylurea, or insulin-treated
- Disease duration since diagnosis
- BMI and obesity class
- Complication status: diabetic kidney disease, retinopathy, or peripheral neuropathy where documented
- Cardiometabolic comorbidity: hypertension, dyslipidaemia, metabolic liver disease
- Matched healthy controls available
Product Features
- Collected from clinically confirmed T2D donors
- Research Use Only (RUO)
- Processed and frozen within 24 hours of collection
- IRB-approved protocols with documented consent
- Custom aliquot volumes available upon request
- Longitudinal collections from the same donor available by request
De-identified Donor Data
- Diagnosis confirmation
- Age, sex assigned at birth, and race/ethnicity
- Donor-reported medications, allergy and infectious disease history
- Comorbidities and treatment history where available
- Additional T2D-specific metadata available on request
Applications
- Insulin, C-peptide and proinsulin measurement for insulin resistance and beta-cell function research
- Adipokine profiling, including leptin and adiponectin
- Metabolic inflammation studies using TNF-alpha, IL-6 and high-sensitivity CRP
- Lipidomic and metabolomic profiling of dysglycaemia
- Biomarker discovery for diabetic kidney disease and other microvascular complications
- Diagnostic and companion-assay development using disease-state serum as a clinically relevant matrix
- Proteomic comparison of treatment-naive versus pharmacologically treated donors
- Therapeutic candidate screening and target validation in metabolic disease
Other Type 2 Diabetes Specimen Types
- Type 2 Diabetes Plasma
- Type 2 Diabetes Whole Blood
- Type 2 Diabetes PBMC
- Type 2 Diabetes Leukopak
- Type 2 Diabetes Bulk Plasma
Compliance and Quality Assurance
- IRB-approved and HIPAA-compliant protocols
- Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
- Documentation support available for regulatory review
Ordering & Customization
Type 2 diabetes serum is available in standard and custom volumes. For pricing, availability, or to discuss a stratified cohort, email learnmore@sanguinebio.com. For international orders or documentation requirements, please contact us to ensure compatibility with your country’s regulations. To browse serum across all disease states and healthy donors, visit our human serum page.
Applications
- Immunology and translational research
- Biomarker discovery and validation
- Drug screening and assay development
- Vaccine and infectious disease research
Product Features
- Research Use Only (RUO), Serum
- Sourced from screened, consented donors
- Processed under validated SOPs
- QC tested for purity, viability, and sterility
- Processed within 24 hours of collection
- IRB-approved protocols with electronic informed consent
Donor Metadata
- Verified diagnosis and clinical history
- Demographic data: age, sex assigned at birth, race/ethnicity
- Medication and treatment background when available
Compliance and Quality Assurance
- IRB-approved collections and standardized procedures
- 21 CFR Part 11-compliant e-consent system
- HIPAA-compliant data management
Ordering & Customization
Human Serum are available in customizable aliquot sizes. For international orders or documentation needs, please contact learnmore@sanguinebio.com to confirm requirements and availability. We also work with multiple ordering platforms and distributors, learn more here.
Protocols & Documentation
-
Download
Serum Isolation
Protocol for serum preparation from whole blood, including collection handling, clarification, and quality documentation.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
Serum
Where can I find your complete catalog?
You can find our full product catalog here.
How long can samples be stored?
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
What customization options are available?
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
Do you offer prospective collections?
Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.
What is the turnaround time for custom collections?
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
Do you have samples in stock?
YES - we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
What does unique donor mean?
Each sample from a different individual - Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
Are samples collected under IRB-approved protocols?
YES - "IRB-approved collection protocols" and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Frequently Asked Questions
Ask a Question
Pair with a Healthy Control
Match your Type 2 Diabetes Serum with normal donor samples for comparison
Healthy Serum
View InventoryNeed a custom Serum cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.